Biotech's 'sug­ar high' led to a cor­rec­tion, but win­ter dol­drums could make way for a turn­around sto­ry this fall

Illustration: Assistant editor Kathy Wong for Endpoints News

In drug de­vel­op­ment, the run­ning joke is that you can con­duct well-con­trolled ex­per­i­ments, with a place­bo arm and a study drug co­hort.

“You can’t do …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.